News
ACRP Appoints Advarra Executive Sergio Armani to Board of Trustees
The Association of Clinical Research Professionals (ACRP) has appointed Sergio Armani, Advarra VP of Business Development, to its Board of Trustees. The appointment is effective January 1, 2020.
Holiday Meeting Schedule – Winter Holidays
Advarra’s offices will be closed Wednesday, December 25, through Wednesday, January 1. During this time, the IRB and IBC will not meet.
Advarra Biosafety Director Contributes to Lab Manager Magazine
Advarra Director of Biosafety Services Dan Eisenman recently contributed to an article in Lab Manager Magazine
Advarra Announces Intent to Acquire Forte, Market-Leading Provider of Clinical Technology Solutions
Advarra is pleased to announce the intent to acquire Forte, the industry’s leading provider of standards-based clinical research technology solutions.
Bloomberg Law Features Advarra Chief Compliance Officer on New Ethics for Fitbit Data
Advarra Chief Compliance Officer and Institutional Official Michele Russell Einhorn was recently featured in Bloomberg Law on Your Fitbit Data Means New Ethics Conundrums for Clinical Trials.
Operating Schedule (9/16-9/17) – Advarra Operations Summit
Advarra’s Regulatory and Operations teams will be out of office on September 16 and 17, 2019, for an off-site, team customer service training.
Advarra Announces Recapitalization with Investment from Genstar Capital
Transaction to Accelerate Growth in Industry-Leading Compliance Business Focused on Increasing Safety and Efficiency in Clinical Trials
I-ACT for Children Selects Advarra as Central IRB for Its Pediatric Clinical Trial Network
Advarra announced today that it has been selected by the Institute for Advanced Clinical Trials for Children (I-ACT for Children) to provide central institutional review board (IRB) services to the organization’s pediatric clinical trial site network.
NIH Guidelines Revised to Streamline Oversight of Gene Therapy Research
NIH OSP has revised the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules to eliminate duplicative regulatory oversight.
Advarra Acquires Quorum Review IRB and Kinetiq Research and Technology Consulting
Advarra is pleased to announce the acquisition of Quorum, one of the most preferred central IRBs in the U.S. and Canada.
How-To Videos Provide Quick, Straightforward Help with Common CIRBI Activities
Short how-to videos are now available to assist users with common features and capabilities of the Advarra Center for IRB Intelligence (CIRBI) Platform.
Holiday Meeting Schedule – Presidents Day (US)/Family Day (Canada)
Advarra’s US and Canadian offices will be closed Monday, February 18th. The IRB and IBC will not meet on Monday, February 18th.
Subscribe to our monthly email
Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.
Advancing Clinical Research: Safer, Smarter, Faster™
Copyright © 2024 Advarra. All Rights Reserved.